Short Interest in CSL Limited (OTCMKTS:CSLLY) Rises By 151.1%

CSL Limited (OTCMKTS:CSLLY) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 11,800 shares, an increase of 151.1% from the December 15th total of 4,700 shares. Based on an average daily trading volume, of 159,800 shares, the days-to-cover ratio is presently 0.1 days.

CSL Stock Performance

CSL stock opened at $87.26 on Thursday. CSL has a 52 week low of $83.31 and a 52 week high of $109.00. The company’s 50 day moving average price is $89.40 and its two-hundred day moving average price is $96.63. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.18 and a quick ratio of 0.97.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.